CDKN1B and breast carcinoma: These results indicated that (a) the activity of -1797 p27 recapitulated the differential breast cancer preventive efficacy of 4-hydroxytamoxifen and tamoxifen and that (b) the estrogen receptor (ER) was not involved in the activation of -1797 p27.